# Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke

> **NCT04674293** · — · UNKNOWN · sponsor: **Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health** · enrollment: 500 (estimated)

## Conditions studied

- The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase

## Interventions

- **DRUG:** Revelisa

## Key facts

- **NCT ID:** NCT04674293
- **Lead sponsor:** Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04674293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04674293, "Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04674293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*